Original Report

Barriers to palliative care research for emergency department patients with advanced cancer


 

Background Patients with advanced cancer often visit the emergency department (ED). Little is known about their willingness or ability to engage in palliative care research, although enrollment in clinical trials of other seriously ill ED patients -- those with stroke, for example -- has been shown to be feasible.

Objective To identify barriers to the enrollment of ED patients with advanced cancer in palliative care research.

Methods We prospectively tracked factors that affected patient accrual into a trial of palliative care for adults with metastatic solid tumors at an urban, academic ED. Research staff screened the electronic medical records for patients admitted to the hospital with metastatic solid tumors 8-12 hours a day, Monday through Friday. The ED attending of record and the patient’s medical oncologist had to agree before research staff invited the patient to participate. Informed consent was obtained at the bedside in the ED, and patients were offered a $20 incentive to participate.

Results Attempts were made to enroll 150 eligible patients in the study, and 73 were enrolled (49% enrollment rate). Barriers to enrollment for the 77 patients who did not participate were deduced from the field notes and placed into the following categories: patient refusal (n = 38, 49%), diagnostic uncertainty regarding cancer stage (n = 11, 14%), symptom burden (n = 9, 12%), family refusal (n = 7, 9%), physician refusal (n = 7, 9%), and/or patient unaware of illness or stage (n = 5, 7%).

Limitations The findings are descriptive and do not test predetermined hypotheses.

Conclusion Patient refusal, symptom burden, and diagnostic disparities are common barriers encountered when recruiting ED patients with advanced cancer. Despite the barriers, recruitment was feasible for such ED patients.

Funding/sponsor This study was funded by a Mentored Research Scholar Grant from the American Cancer Society (Dr Grudzen), a Medical Student Training in Aging Research Grant from the American Federation on Aging (Mr Kandarian), and by a Mid- Career Investigator Award in Patient Oriented Research (K24 AG022345) from the National Institute on Aging (Dr Morrison).


Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

End-of-life home care utilization and costs in patients with advanced colorectal cancer
MDedge Hematology and Oncology
Taking on racial and ethnic disparities in cancer care
MDedge Hematology and Oncology
Late referral to palliative care consultation service: length of stay and in-hospital mortality outcomes
MDedge Hematology and Oncology
The late effects of cancer and cancer treatment: a rapid review
MDedge Hematology and Oncology
Topical lidocaine reduces menopausal dyspareunia
MDedge Hematology and Oncology
AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics
MDedge Hematology and Oncology
Biologic agents do not up recurrent cancer risk in RA
MDedge Hematology and Oncology
Oncology community scrutinizing obstacles to personalized medicine
MDedge Hematology and Oncology
No link seen between ondansetron and tachyarrhythmias in healthy children
MDedge Hematology and Oncology
Taking the data and findings into the real-world setting
MDedge Hematology and Oncology